351 related articles for article (PubMed ID: 17885234)
1. MR imaging of metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings.
Kim E; Na DG; Kim EY; Kim JH; Son KR; Chang KH
AJNR Am J Neuroradiol; 2007 Oct; 28(9):1652-8. PubMed ID: 17885234
[TBL] [Abstract][Full Text] [Related]
2. Reversible inferior colliculus lesion in metronidazole-induced encephalopathy: magnetic resonance findings on diffusion-weighted and fluid attenuated inversion recovery imaging.
Lee SS; Cha SH; Lee SY; Song CJ
J Comput Assist Tomogr; 2009; 33(2):305-8. PubMed ID: 19346865
[TBL] [Abstract][Full Text] [Related]
3. Metronidazole-induced encephalopathy and inferior olivary hypertrophy: lesion analysis with diffusion-weighted imaging and apparent diffusion coefficient maps.
Seok JI; Yi H; Song YM; Lee WY
Arch Neurol; 2003 Dec; 60(12):1796-800. PubMed ID: 14676060
[TBL] [Abstract][Full Text] [Related]
4. Acute metronidazole-induced neurotoxicity: an update on MRI findings.
Patel L; Batchala P; Almardawi R; Morales R; Raghavan P
Clin Radiol; 2020 Mar; 75(3):202-208. PubMed ID: 31858989
[TBL] [Abstract][Full Text] [Related]
5. [Reversible changes on MR images in a patient with metronidazole-induced encephalopathy].
Neshige S; Kanaya Y; Takeshima S; Yoshimoto T; Tanaka A; Kuriyama M
Rinsho Shinkeigaku; 2015; 55(3):174-7. PubMed ID: 25786755
[TBL] [Abstract][Full Text] [Related]
6. Correlation of magnetic resonance images with neuropathology of irreversible metronidazole-induced encephalopathy: an autopsy case report.
Miki Y; Takeuchi Y; Murasawa S; Takayasu S; Tsushima F; Kakeda S; Mizukami H; Wakabayashi K
BMC Neurol; 2022 Dec; 22(1):485. PubMed ID: 36522715
[TBL] [Abstract][Full Text] [Related]
7. Metronidazole-induced encephalopathy: not always a reversible situation.
Hobbs K; Stern-Nezer S; Buckwalter MS; Fischbein N; Finley Caulfield A
Neurocrit Care; 2015 Jun; 22(3):429-36. PubMed ID: 25561434
[TBL] [Abstract][Full Text] [Related]
8. MRI Findings and Topographic Distribution of Lesions in Metronidazole-Induced Encephalopathy.
Fatima A; Khanduri S; Sultana S; Surbhi ; Siddiqui SA; Gupta A; Pathak V; Mulani M; Khan S; Bansal T
Cureus; 2022 Sep; 14(9):e29145. PubMed ID: 36282977
[TBL] [Abstract][Full Text] [Related]
9. Metronidazole-induced encephalopathy with contrast enhancing lesions on MRI.
Furukawa S; Yamamoto T; Sugiyama A; Ohira K; Aotsuka Y; Koide K; Kojima K; Kuwabara S
J Neurol Sci; 2015 May; 352(1-2):129-31. PubMed ID: 25865108
[No Abstract] [Full Text] [Related]
10. Symmetrical central tegmental tract (CTT) hyperintense lesions on magnetic resonance imaging in children.
Yoshida S; Hayakawa K; Yamamoto A; Aida N; Okano S; Matsushita H; Kanda T; Yamori Y; Yoshida N; Hirota H
Eur Radiol; 2009 Feb; 19(2):462-9. PubMed ID: 18795297
[TBL] [Abstract][Full Text] [Related]
11. High b-value diffusion-weighted MR imaging of normal brain at 3T.
Cihangiroglu M; Uluğ AM; Firat Z; Bayram A; Kovanlikaya A; Kovanlikaya I
Eur J Radiol; 2009 Mar; 69(3):454-8. PubMed ID: 18162352
[TBL] [Abstract][Full Text] [Related]
12. Subarachnoid hemorrhage in the subacute stage: elevated apparent diffusion coefficient in normal-appearing brain tissue after treatment.
Liu Y; Soppi V; Mustonen T; Könönen M; Koivisto T; Koskela A; Rinne J; Vanninen RL
Radiology; 2007 Feb; 242(2):518-25. PubMed ID: 17179395
[TBL] [Abstract][Full Text] [Related]
13. Evolution of lesions in Susac syndrome at serial MR imaging with diffusion-weighted imaging and apparent diffusion coefficient values.
White ML; Zhang Y; Smoker WR
AJNR Am J Neuroradiol; 2004 May; 25(5):706-13. PubMed ID: 15140708
[TBL] [Abstract][Full Text] [Related]
14. Atypical diffusion-restricted lesion in 5-Fluorouracil encephalopathy.
Lee WW; Kim JS; Son KR; Kwon HM
AJNR Am J Neuroradiol; 2012 Aug; 33(7):E102-3. PubMed ID: 22403780
[TBL] [Abstract][Full Text] [Related]
15. Diffusion MR imaging of hypoglycemic encephalopathy.
Kang EG; Jeon SJ; Choi SS; Song CJ; Yu IK
AJNR Am J Neuroradiol; 2010 Mar; 31(3):559-64. PubMed ID: 19875472
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
17. [Metronidazole-Induced Encephalopathy during Brain Abscess Treatment:Two Case Reports].
Yokoyama Y; Asaoka K; Sugiyama T; Uchida K; Shimbo D; Kobayashi S; Itamoto K
No Shinkei Geka; 2015 Oct; 43(10):927-32. PubMed ID: 26435373
[TBL] [Abstract][Full Text] [Related]
18. Isolated involvement of corpus callosum in metronidazole-induced encephalopathy with concomitant peripheral neuropathy: A case report.
Peng Q; You Q; Zhang J; Liu S
Medicine (Baltimore); 2020 May; 99(20):e20198. PubMed ID: 32443341
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted MR of the brain: methodology and clinical application.
Mascalchi M; Filippi M; Floris R; Fonda C; Gasparotti R; Villari N
Radiol Med; 2005 Mar; 109(3):155-97. PubMed ID: 15775887
[TBL] [Abstract][Full Text] [Related]
20. Sequential occurrence of eclampsia-associated posterior reversible encephalopathy syndrome and reversible splenial lesion syndrome (a case report): proposal of a novel pathogenesis for reversible splenial lesion syndrome.
Yang Q; Chang CC; Liu M; Yu YQ
BMC Med Imaging; 2019 Apr; 19(1):35. PubMed ID: 31039748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
